Reversing stage III oral adenocarcinoma in a dog treated with anti-canine PD-1 therapeutic antibody: a case report.

Xu, Shuo; Xie, Jingshu; Wang, Shuaiyu; Tang, Na; Feng, Junli; Su, Youhong; Li, Gebin

Xu, Shuo; Xie, Jingshu; Wang, Shuaiyu; Tang, Na; Feng, Junli; Su, Youhong; Li, Gebin.

Afiliación

Xu S; College of Veterinary Medicine, China Agricultural University, Beijing, China.
Xie J; Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China.
Wang S; College of Veterinary Medicine, China Agricultural University, Beijing, China.
Tang N; College of Veterinary Medicine, China Agricultural University, Beijing, China.
Feng J; College of Veterinary Medicine, China Agricultural University, Beijing, China.
Su Y; Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China.
Li G; College of Veterinary Medicine, China Agricultural University, Beijing, China.

Front Vet Sci ; 10: 1144869, 2023.

Article en En | MEDLINE | ID: mdl-37252387

Palabras clave

canine; immunotherapy; monoclonal antibody; partial remission; programmed cell death receptor 1; salivary gland carcinoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Vet Sci Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google